BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 2121913)

  • 1. Can iodine-131 whole-body scan be replaced by thyroglobulin measurement in the post-surgical follow-up of differentiated thyroid carcinoma?
    Ronga G; Fiorentino A; Paserio E; Signore A; Todino V; Tummarello MA; Filesi M; Baschieri I
    J Nucl Med; 1990 Nov; 31(11):1766-71. PubMed ID: 2121913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complementary role of whole body scan and serum thyroglobulin determination in the follow-up of differentiated thyroid carcinoma.
    Ronga G; Fiorentino A; Fragasso G; Fringuelli FM; Todino V
    Ital J Surg Sci; 1986; 16(1):11-5. PubMed ID: 3087907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum thyroglobulin and whole-body scanning as markers in the follow-up of differentiated thyroid carcinomas].
    Degrossi OJ; Rozados IB; Damilano S; Degrossi EB; de Ganino L; Pinkas M; García del Río H; Artagaveytía D
    Medicina (B Aires); 1991; 51(4):291-5. PubMed ID: 1821916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The correlation between serum thyroglobulin and iodine-131 scanning in detecting metastases in patients with a differentiated thyroid carcinoma].
    Abduluakhab M; Gavrilov M; Mladenov B
    Khirurgiia (Sofiia); 1997; 50(4):33-6. PubMed ID: 9739856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma.
    Lubin E; Mechlis-Frish S; Zatz S; Shimoni A; Segal K; Avraham A; Levy R; Feinmesser R
    J Nucl Med; 1994 Feb; 35(2):257-62. PubMed ID: 8294995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of serum thyroglobulin determination in the follow-up of differentiated carcinomas of the thyroid].
    Secades Ariz I; Pérez Piqueras JL; Labanda Tejedor P; Cordero Peinado J
    An Med Interna; 1988 Sep; 5(9):439-43. PubMed ID: 2856622
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of iodine-131 and thallium-201 imaging and serum thyroglobulin in the management of differentiated thyroid carcinoma.
    Dadparvar S; Krishna L; Brady LW; Slizofski WJ; Brown SJ; Chevres A; Micaily B
    Cancer; 1993 Jun; 71(11):3767-73. PubMed ID: 8490927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serum thyroglobulin in the diagnosis of metastases of differentiated thyroid cancer. Effect of suppressive thyroid hormone substitution on the diagnostic accuracy of thyroglobulin values].
    Müller-Gärtner HW; Schneider C; Tempel MT
    Nuklearmedizin; 1986 Oct; 25(5):194-200. PubMed ID: 3797259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome in patients with differentiated thyroid cancer with negative diagnostic whole-body scanning and detectable stimulated thyroglobulin.
    van Tol KM; Jager PL; de Vries EG; Piers DA; Boezen HM; Sluiter WJ; Dullaart RP; Links TP
    Eur J Endocrinol; 2003 Jun; 148(6):589-96. PubMed ID: 12773129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum thyroglobulin in the management of thyroid cancer.
    Blahd WH
    J Nucl Med; 1990 Nov; 31(11):1771-3. PubMed ID: 2121914
    [No Abstract]   [Full Text] [Related]  

  • 11. Thyroglobulin measurements in the follow-up of patients with differentiated thyroid carcinoma: comparison with quantitative radioactive iodine uptake measurements and total body scans.
    Bolk JH; Bussemaker JK; Nieuwenhuijzen Kruseman AC; De Vijlder JJ; Goslings BM
    Neth J Med; 1985; 28(9):340-6. PubMed ID: 4047268
    [No Abstract]   [Full Text] [Related]  

  • 12. Follow-up of differentiated thyroid cancer.
    Pacini F
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S492-6. PubMed ID: 12192551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum thyroglobulin concentrations and whole-body radioiodine scan in follow-up of differentiated thyroid cancer after thyroid ablation.
    Ng Tang Fui SC; Hoffenberg R; Maisey MN; Black EG
    Br Med J; 1979 Aug; 2(6185):298-300. PubMed ID: 476434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of initial iodine-131 whole-body scan and serum thyroglobulin in differentiated thyroid carcinoma metastases.
    Filesi M; Signore A; Ventroni G; Melacrinis FF; Ronga G
    J Nucl Med; 1998 Sep; 39(9):1542-6. PubMed ID: 9744339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thallium-201 scintigraphy in differentiated thyroid cancer: comparison with radioiodine scintigraphy and serum thyroglobulin determinations.
    Ramanna L; Waxman A; Braunstein G
    J Nucl Med; 1991 Mar; 32(3):441-6. PubMed ID: 2005453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical value of serum thyroglobulin and 131I-whole body retention measurements in the diagnosis of metastases from differentiated thyroid carcinoma (author's transl)].
    Weissel M; Bergmann H; Höfer R
    Acta Med Austriaca; 1980; 7(4-5):114-9. PubMed ID: 7246011
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum thyroglobulin concentrations and 131I whole body scans in the diagnosis of metastases from differentiated thyroid carcinoma (after thyroidectomy).
    Pacini F; Pinchera A; Giani C; Grasso L; Baschieri L
    Clin Endocrinol (Oxf); 1980 Jul; 13(1):107-10. PubMed ID: 7438460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroglobulin and 131I uptake of remaining tissue in patients with differentiated carcinoma after thyroidectomy.
    Moser E; Fritsch S; Braun S
    Nucl Med Commun; 1988 Apr; 9(4):262-6. PubMed ID: 3399222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma in children.
    Antonelli A; Miccoli P; Fallahi P; Ferrari SM; Grosso M; Boni G; Berti P
    Surgery; 2006 Dec; 140(6):1035-41; discussion 1041-2. PubMed ID: 17188154
    [No Abstract]   [Full Text] [Related]  

  • 20. Thallium-201 uptake with negative iodine-131 scintigraphy and serum thyroglobulin in metastatic oxyphilic papillary thyroid carcinoma.
    Harder W; Lind P; Molnar M; Mikosch P; Gomez I; Gallowitsch HJ; Kresnik E; Unterweger O; Dinges HP
    J Nucl Med; 1998 Feb; 39(2):236-8. PubMed ID: 9476925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.